Neurocrine Biosciences
NBIX
#1686
Rank
NZ$21.58 B
Marketcap
NZ$215.11
Share price
-1.99%
Change (1 day)
33.00%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

We have found no dividend yield history for this company